[go: up one dir, main page]

AUPR103800A0 - Compositions for the treatment of endothelial dysfunction - Google Patents

Compositions for the treatment of endothelial dysfunction

Info

Publication number
AUPR103800A0
AUPR103800A0 AUPR1038A AUPR103800A AUPR103800A0 AU PR103800 A0 AUPR103800 A0 AU PR103800A0 AU PR1038 A AUPR1038 A AU PR1038A AU PR103800 A AUPR103800 A AU PR103800A AU PR103800 A0 AUPR103800 A0 AU PR103800A0
Authority
AU
Australia
Prior art keywords
compositions
treatment
endothelial dysfunction
dysfunction
endothelial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR1038A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Western Australia
Original Assignee
University of Western Australia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Western Australia filed Critical University of Western Australia
Priority to AUPR1038A priority Critical patent/AUPR103800A0/en
Publication of AUPR103800A0 publication Critical patent/AUPR103800A0/en
Priority to DE60117046T priority patent/DE60117046T2/en
Priority to ES01988586T priority patent/ES2257457T3/en
Priority to DK01988586T priority patent/DK1328266T3/en
Priority to SI200130505T priority patent/SI1328266T1/en
Priority to RU2003111175/15A priority patent/RU2003111175A/en
Priority to CZ20031148A priority patent/CZ301282B6/en
Priority to AU2176502A priority patent/AU2176502A/en
Priority to AT01988586T priority patent/ATE316787T1/en
Priority to HK04100253.8A priority patent/HK1057340B/en
Priority to CNB01817972XA priority patent/CN1220488C/en
Priority to CA2426625A priority patent/CA2426625C/en
Priority to EEP200300165A priority patent/EE05281B1/en
Priority to MXPA03003733A priority patent/MXPA03003733A/en
Priority to HU0303566A priority patent/HUP0303566A3/en
Priority to PT01988586T priority patent/PT1328266E/en
Priority to US10/399,639 priority patent/US7410983B2/en
Priority to PL361635A priority patent/PL212952B1/en
Priority to SK508-2003A priority patent/SK287992B6/en
Priority to DZ013442A priority patent/DZ3442A1/en
Priority to BR0114701-3A priority patent/BR0114701A/en
Priority to IL15552401A priority patent/IL155524A0/en
Priority to PCT/EP2001/012425 priority patent/WO2002034259A1/en
Priority to AU2002221765A priority patent/AU2002221765B2/en
Priority to KR1020037004793A priority patent/KR100862129B1/en
Priority to JP2002537311A priority patent/JP4236464B2/en
Priority to EP01988586A priority patent/EP1328266B1/en
Priority to TNTNSN01151A priority patent/TNSN01151A1/en
Priority to ARP010105032A priority patent/AR035071A1/en
Priority to IL155524A priority patent/IL155524A/en
Priority to ZA200303126A priority patent/ZA200303126B/en
Priority to NO20031851A priority patent/NO332260B1/en
Priority to BG107765A priority patent/BG65979B1/en
Priority to MA27124A priority patent/MA25847A1/en
Priority to CY20061100400T priority patent/CY1105007T1/en
Abandoned legal-status Critical Current

Links

AUPR1038A 2000-10-26 2000-10-26 Compositions for the treatment of endothelial dysfunction Abandoned AUPR103800A0 (en)

Priority Applications (35)

Application Number Priority Date Filing Date Title
AUPR1038A AUPR103800A0 (en) 2000-10-26 2000-10-26 Compositions for the treatment of endothelial dysfunction
EP01988586A EP1328266B1 (en) 2000-10-26 2001-10-23 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
US10/399,639 US7410983B2 (en) 2000-10-26 2001-10-23 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
PL361635A PL212952B1 (en) 2000-10-26 2001-10-23 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
DK01988586T DK1328266T3 (en) 2000-10-26 2001-10-23 Combination of fenofibrate and coenzyme Q10 to treat endothelial dysfunction
SI200130505T SI1328266T1 (en) 2000-10-26 2001-10-23 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
RU2003111175/15A RU2003111175A (en) 2000-10-26 2001-10-23 Phenofibrate and Coenzyme Q10 Combination for the Treatment of Endothelial Dysfunction
CZ20031148A CZ301282B6 (en) 2000-10-26 2001-10-23 Phenofibrate and coenzyme Q10 mixture intended for treating endothelium dysfunction
AU2176502A AU2176502A (en) 2000-10-26 2001-10-23 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
AT01988586T ATE316787T1 (en) 2000-10-26 2001-10-23 COMBINATION OF FENOFIBRATE AND COENZYME Q10 FOR THE TREATMENT OF ENDOTHELIAL DISFUNCTION
HK04100253.8A HK1057340B (en) 2000-10-26 2001-10-23 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
CNB01817972XA CN1220488C (en) 2000-10-26 2001-10-23 Compositions of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction
CA2426625A CA2426625C (en) 2000-10-26 2001-10-23 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
EEP200300165A EE05281B1 (en) 2000-10-26 2001-10-23 Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction
MXPA03003733A MXPA03003733A (en) 2000-10-26 2001-10-23 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction.
HU0303566A HUP0303566A3 (en) 2000-10-26 2001-10-23 Pharmaceutical composition containing combination of fenofibrate and coenzyme q10 and its use for the treatment of endothelial dysfunction
PT01988586T PT1328266E (en) 2000-10-26 2001-10-23 COMBINATION OF PHENOFIBRATE AND COENZYME Q10 FOR THE TREATMENT OF ENDOTHELIAL DISFUNCTION
DE60117046T DE60117046T2 (en) 2000-10-26 2001-10-23 COMBINATION OF FENOFIBRATE AND COENZYME Q10 FOR THE TREATMENT OF ENDOTHELIAL MISSING FUNCTION
SK508-2003A SK287992B6 (en) 2000-10-26 2001-10-23 Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction
ES01988586T ES2257457T3 (en) 2000-10-26 2001-10-23 COMBINATION OF PHENOFIBRATE AND COENZYME Q10 FOR THE TREATMENT OF ENDOTELIAL DYSFUNCTION.
DZ013442A DZ3442A1 (en) 2000-10-26 2001-10-23 COMBINATION OF FENOFIBRATE AND COENZYME Q10 FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION
BR0114701-3A BR0114701A (en) 2000-10-26 2001-10-23 Fenofibrate and coenzyme q 10 combination for treatment of endothelial dysfunction
IL15552401A IL155524A0 (en) 2000-10-26 2001-10-23 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
PCT/EP2001/012425 WO2002034259A1 (en) 2000-10-26 2001-10-23 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
AU2002221765A AU2002221765B2 (en) 2000-10-26 2001-10-23 Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction
KR1020037004793A KR100862129B1 (en) 2000-10-26 2001-10-23 Combination of Fenofibrate and Coenzyme Cutene for Treatment of Endothelial Dysfunction
JP2002537311A JP4236464B2 (en) 2000-10-26 2001-10-23 Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction
TNTNSN01151A TNSN01151A1 (en) 2000-10-26 2001-10-25 Compositions for the treatment of endothelial dysfunction
ARP010105032A AR035071A1 (en) 2000-10-26 2001-10-26 COMPOUNDS FOR THE TREATMENT OF ENDOTELIAL DYSFUNCTION; METHOD FOR PRODUCING THESE PHARMACEUTICAL COMPOUNDS; USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
IL155524A IL155524A (en) 2000-10-26 2003-04-21 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
ZA200303126A ZA200303126B (en) 2000-10-26 2003-04-23 Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction.
NO20031851A NO332260B1 (en) 2000-10-26 2003-04-24 Composition comprising a peroxisome proliferator activated receptor (PPAR) activator selected from a fibrate, a thiazolidinedione and a benzoquinone selected from ubiquinone, a pharmaceutical composition comprising the same and a method of preparing such, such compositions for use in therapy and the use of such compositions for treatment of disease
BG107765A BG65979B1 (en) 2000-10-26 2003-04-25 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
MA27124A MA25847A1 (en) 2000-10-26 2003-04-25 COMPOSITION FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION.
CY20061100400T CY1105007T1 (en) 2000-10-26 2006-03-21 COMBINATION OF FENOFIBRATE AND COENZYME Q10 FOR THE THERAPEUTIC TREATMENT OF ENDOTHELIAL DYSFUNCTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR1038A AUPR103800A0 (en) 2000-10-26 2000-10-26 Compositions for the treatment of endothelial dysfunction

Publications (1)

Publication Number Publication Date
AUPR103800A0 true AUPR103800A0 (en) 2000-11-16

Family

ID=3825085

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR1038A Abandoned AUPR103800A0 (en) 2000-10-26 2000-10-26 Compositions for the treatment of endothelial dysfunction

Country Status (2)

Country Link
AU (1) AUPR103800A0 (en)
ZA (1) ZA200303126B (en)

Also Published As

Publication number Publication date
ZA200303126B (en) 2004-04-23

Similar Documents

Publication Publication Date Title
AU2001272849A1 (en) Composition for the treatment of osteoarthritis
AU2001272852A1 (en) Composition for the treatment of migraine
AU2001268659A1 (en) Water treatment compositions
AU2001269939A1 (en) Methods for eliminating the formation of biofilm
AUPR105400A0 (en) Processes and compositions for water treatment
IL154292A0 (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell profiliferation
PL346926A1 (en) Ophthalmic compositions
AU2001286233A1 (en) Cement composition
AU3276802A (en) Background of the invention
AU2001295503A1 (en) Composition for the elimination of autoreactive b-cells
AU2001233081A1 (en) Composition for treatment of stress
AU2003296490A1 (en) Rhamnan sulphate composition for treatment of endothelial dysfunction
AU2001250821A1 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
AU2002338709A1 (en) Workability-improving agents for cement compositions
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2002219080A1 (en) Cleaning compositions
NZ524418A (en) Highly purified simvastatin compositions
AU2001241098A1 (en) Composition
AU2001244562A1 (en) Neovascularization inhibitors
HUP0300860A3 (en) Pharmaceutical compositions suitable for treatment of urinary dysfunction
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU7652400A (en) Novel combination for the treatment of sexual dysfunction
AU2001265425A1 (en) Compositions for treating biofilm
AUPR103800A0 (en) Compositions for the treatment of endothelial dysfunction
AU1530601A (en) Biocide compositions